Immune system (Broad cellular immunomodulation)

The immune system is a complex network of cells, tissues, and organs that work together to defend the body against attacks by foreign invaders (NIH, 2023). Broad cellular immunomodulation refers to therapeutic strategies that aim to alter the immune response at a systemic or multi-cellular level rather than through a single molecular interaction with a specific receptor or enzyme. This approach is frequently employed in the management of autoimmune diseases, transplant rejection, and systemic inflammatory syndromes where the underlying pathology is multifactorial and involves overlapping pathways (StatPearls, 2023). Drugs and therapies in this category, such as mesenchymal stem cells or intravenous immunoglobulins, exert their effects by shifting the balance of pro-inflammatory and anti-inflammatory signals across various cell populations like T-cells and macrophages (PubMed, 2022). While these broad-acting therapies can be highly effective for complex diseases, they often carry risks of non-specific effects, including global immunosuppression and increased vulnerability to infections (NIH, 2024). Consequently, clinical monitoring often focuses on systemic markers of inflammation and overall immune cell counts rather than a single molecular biomarker.

Other names

Broad immunomodulationSystemic immune modulationCellular immunotherapyNon-specific immunomodulation

Broad suppression or activation of multiple immune cell subsets (T-cells, B-cells, macrophages) and systemic modulation of cytokine signaling pathways to restore immune balance.